| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/15/2011 | EP2332975A1 Human proteins |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332973A2 Differential in tumour gene products and use of same |
| 06/15/2011 | EP2332972A1 Novel Beta-Actin and RPS21 promoters and uses thereof |
| 06/15/2011 | EP2332961A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 06/15/2011 | EP2332958A1 Detection of nucleic and sequence differences using the ligase detection reaction with addressable arrays |
| 06/15/2011 | EP2332957A1 Detection of nucleic and acid sequence differences using the ligase detection reaction with addressable arrays |
| 06/15/2011 | EP2332955A2 Antisense modulation of acyl CoA cholesterol acyltransferase-2 expression |
| 06/15/2011 | EP2332896A2 Evolving new molecular function |
| 06/15/2011 | EP2332645A1 Apparatus for chemical and biochemical reactions using photo-generated reagents |
| 06/15/2011 | EP2332582A1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332574A1 HCV NS3/4A Sequences |
| 06/15/2011 | EP2332573A1 Chimeric alphavirus replicon particles |
| 06/15/2011 | EP2332572A1 Nucleic acid vaccines for prevention of Flavivirus |
| 06/15/2011 | EP2332561A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
| 06/15/2011 | EP2331708A1 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 06/15/2011 | EP2331697A2 Methods concerning ppar delta and antagonists thereof |
| 06/15/2011 | EP2331696A1 Methods for the production of ips cells |
| 06/15/2011 | EP2331695A2 Nucleic acids encoding desaturases and modified plant oil |
| 06/15/2011 | EP2331694A1 Herbicide resistant sunflower plants |
| 06/15/2011 | EP2331693A2 An expression vector and a method thereof |
| 06/15/2011 | EP2331692A1 Modified thromboxane a2 receptor promoter sequence |
| 06/15/2011 | EP2331691A1 Engineered light-emitting reporter genes and medthods of use |
| 06/15/2011 | EP2331690A1 Compositions and methods for inhibiting expression of mutant egfr gene |
| 06/15/2011 | EP2331689A1 Method for cloning avian-derived antibodies |
| 06/15/2011 | EP2331685A1 Plants with altered root architecture, related constructs and methods involving genes encoding protein phophatase 2c (pp2c) polypeptides and homologs thereof |
| 06/15/2011 | EP2331684A1 Production of n-acylated sulphur-containing amino acids with microorganisms having enhanced n-acyltransferase enzymatic activity |
| 06/15/2011 | EP2331683A1 Enhanced dihydroxy-acid dehydratase activity in lactic acid bacteria |
| 06/15/2011 | EP2331681A2 Vector for identification, selection and expression of recombinants |
| 06/15/2011 | EP2331565A2 Hiv-1 envelope polypeptides for hiv vaccine |
| 06/15/2011 | EP2331557A1 Alphavirus packaging cell lines |
| 06/15/2011 | EP2331141A2 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |
| 06/15/2011 | EP2331131A1 Treating cancer by modulating rna helicases |
| 06/15/2011 | EP2331119A1 Malaria vaccine |
| 06/15/2011 | EP2331105A2 Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
| 06/15/2011 | EP2331069A1 Heterogeneous polymeric micelles for intracellular delivery |
| 06/15/2011 | EP2046830B1 Csf3r polypeptides and uses thereof |
| 06/15/2011 | EP2016183B1 Process for chromosomal engineering using a novel dna repair system |
| 06/15/2011 | EP1928901B1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/15/2011 | EP1880009B1 Highly productive recombinant yeast strains with modified galactose-regulated transcription |
| 06/15/2011 | EP1871890B1 Methods and devices for delivering a therapeutic product to the ocular sphere of a subject |
| 06/15/2011 | EP1842921B1 Recombined adenovirus p53 preparation for treating tumor |
| 06/15/2011 | EP1751189B1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 06/15/2011 | EP1651765B1 Novel photobacterium damselae nucleotide and amino acid sequences and uses thereof |
| 06/15/2011 | EP1642981B1 RECOMBINANT GENE MEDICINE OF ADENOVIRUS VECTOR AND GENE p53 FOR TREATING PROLIFERATIVE DISEASES |
| 06/15/2011 | EP1558744B1 Enzymatic encoding |
| 06/15/2011 | EP1530635B1 Ghrelin binding nucleic acids |
| 06/15/2011 | EP1500665B1 METHODS FOR CONSTRUCTING scDb LIBRARIES |
| 06/15/2011 | EP1481061B1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 06/15/2011 | EP1476462B1 Novel fungal lipase |
| 06/15/2011 | EP1438401B1 Production of a transgenic avian by cytoplasmic injection |
| 06/15/2011 | EP1417344B1 Zinc finger domain libraries |
| 06/15/2011 | EP1417229B1 Methods and compounds for the targeting of protein to exosomes |
| 06/15/2011 | EP1404710B1 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 06/15/2011 | EP1392833B1 Site-targeted transformation using amplification vectors |
| 06/15/2011 | EP1373476B1 Cytochrome p450s and uses thereof |
| 06/15/2011 | EP1322765B1 Escherichia coli/ strains which over-produce l-threonine and processes for the production of l-threonine by fermentation |
| 06/15/2011 | EP1282722B1 Stabilized proteins |
| 06/15/2011 | EP1240320B1 Nucleic acid isolation method and kit |
| 06/15/2011 | EP1171619B1 Regulated expression of isopentenyl transferase in maize seeds |
| 06/15/2011 | EP1012274B2 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| 06/15/2011 | EP0939804B2 NEUTROKINE alpha |
| 06/15/2011 | CN201864730U Portable ultraviolet gel cutter |
| 06/15/2011 | CN1974591B SiRNA expression template for treating liver necrosis and liver fibrosis |
| 06/15/2011 | CN1950392B Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 06/15/2011 | CN1942578B Low virulent strain of recombinant newcastle disease lasota vaccine expressing HA protein of avian influenza-H5 virus |
| 06/15/2011 | CN1865275B Artificial single-chain deoxynucleotide having therapeutic effect to human B cell tumour |
| 06/15/2011 | CN1837362B SiRNA for inhibiting expression of SARS coronavirus N protein and encoding gene thereof |
| 06/15/2011 | CN1820734B Treatment with anti-erbb2 antibodies |
| 06/15/2011 | CN1780912B Method for inhibiting cell growth and composition therefor |
| 06/15/2011 | CN1780907B Anti-CCR5 antibody |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
| 06/15/2011 | CN102099481A Self-inactivating helper adenoviruses for the production of high-capacity recombinant adenoviruses |
| 06/15/2011 | CN102099480A Plants having enhanced yield-related traits and a method for making the same |
| 06/15/2011 | CN102099479A Plante brassica comprenant un allele indehiscent mutant |
| 06/15/2011 | CN102099478A Generation of production strains that efficiently express nuclear transgenes |
| 06/15/2011 | CN102099476A Compositions and methods for improving plants |
| 06/15/2011 | CN102099475A Treatment of pain with gap junction modulation compounds |
| 06/15/2011 | CN102099474A Oligonucleotides for treating inflammation and neoplastic cell proliferation |
| 06/15/2011 | CN102099473A Novel therapeutic agents against hepatitis |
| 06/15/2011 | CN102099472A Nucleic acid molecule and method of targeting gene expression to gliomas |
| 06/15/2011 | CN102099471A Aptamer against il-17 and use thereof |
| 06/15/2011 | CN102099470A Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 06/15/2011 | CN102099469A Novel protein having endoglucanase activity, DNA of the protein, and use of the same |
| 06/15/2011 | CN102099468A Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 06/15/2011 | CN102099467A SiRNA of human osteopontin |
| 06/15/2011 | CN102099460A Filamentous fungi with inactivated protease genes for altered protein production |
| 06/15/2011 | CN102099377A CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 06/15/2011 | CN102095852A Double-antibody sandwich method for quickly detecting novel H1N1 influenza virus |
| 06/15/2011 | CN102094082A Identifying method of microsporum canis of rabbit |
| 06/15/2011 | CN102094080A Quick molecular detection method for simultaneously detecting three kinds of fusarium toxins and application thereof |
| 06/15/2011 | CN102094078A Primer for detecting K-ras genic mutation and application thereof |
| 06/15/2011 | CN102094043A Construction and application of recombinant pig chemotactic factor CXCL12 mammalian cell expression plasmid |
| 06/15/2011 | CN102094042A Recombinant vector of ZNF300 gene and application thereof |
| 06/15/2011 | CN102094041A Improvement and transgenic research of wheat genetic transformation system mediated by agrobacterium tumefacien |
| 06/15/2011 | CN102094040A Gene engineering bacterium for producing tryptase, and construction method and application thereof |
| 06/15/2011 | CN102094039A Prokaryotic expression and purification method of transgenic rice Bt protein cry2a |